Cellectar Biosciences (CLRB) Reports FY Loss of $3.11
Tweet
Share
E-mailGet Alerts CLRB Hot Sheet
Join SI Premium – FREE
Cellectar Biosciences (NASDAQ: CLRB) reported FY EPS of ($3.11).
For earnings history and earnings-related data on Cellectar Biosciences (CLRB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
